ELV

Elevance Health
D

ELV

Arincen57/100B

Elevance Health executives and insider trading

Gail Koziara Boudreaux bought 2,725 shares for 1.00M USD and sold 0 for 0 USD on the open market over the last twelve months.

Over the last twelve months Elevance Health's insiders sold 17,157 shares for 6.98M USD in 19 sales on the open market, and bought 6,725 shares in 4 purchases.

Insiders over the last twelve months

Insider sales
19
Shares sold
17,157
Value sold
6.98M USD
Insider purchases
4

Insiders buying against selling

Bought on the market
Sold on the market
0
1 week
0
0
1 month
5.23M USD
0
3 months
5.23M USD
1.37M USD
6 months
6.06M USD
2.24M USD
1 year
6.98M USD
5.05M USD
2 years
10.50M USD
Sold, decided at the timeSold under a Rule 10b5-1 plan set in advance

Open-market purchases and sales reported on Form 4, by value. Awards, option exercises and shares withheld for tax are not counted. Whether a sale was under a Rule 10b5-1 plan is read from each Form 4 at the SEC (the box exists on filings since April 2023).

Executives and directors

The people who run the company and the directors who reported trades, with what each bought and sold on the open market over the last twelve months. The CEO first, then whoever traded most.

NamePositionAgeShares sold (12 months)Value sold (12 months)Shares bought (12 months)Last saleShares held after
Gail Koziara Boudreaux CEOPresident, Chief Executive Officer & Director65——2,725—171,976
Mark Bradley Kaye Executive Vice President & Chief Financial Officer4610,5844.66M USD—22 Oct 202630,103
Charles Morgan Kendrick Jr. EVP and President of Commercial & Specialty Health Benefits603,196910.60K USD—6 Mar 202611,791
Steven H Collis Director———3,000—4,202
Ronald William Penczek Senior Vice President, Controller & Chief Accounting Officer611,900765.96K USD—12 Jun 20263,740
Ratnakar Lavu EVP & Chief Digital Info Ofr—1,300572.00K USD—5 Nov 202614,849
Ramiro G Peru Director———1,000—10,908
Robert L Jr Dixon Director—15160.67K USD—11 Jun 202610,734
Amy W Schulman Director—267.48K USD—12 Mar 2026781

Insider sales and purchases by quarter

How many insider sales and purchases were reported each quarter.

Insider sales Insider purchases

Every insider transaction

Insiders must report every trade in the company's shares to the SEC within two business days, on Form 4. Only purchases and sales are trades on the open market; awards, option exercises, shares withheld for tax and gifts come with pay, and the twelve-month totals leave them out.

DateNameTransactionSharesPriceValueShares held afterFiling
5 Nov 2026Ratnakar LavuSale1,300440.00572.00K USD14,849Form 4
22 Oct 2026Mark Bradley KayeSale400434.00173.60K USD30,103Form 4
22 Oct 2026Mark Bradley KayeSale321435.25139.72K USD29,782Form 4
22 Oct 2026Mark Bradley KayeSale1,660436.20724.09K USD28,122Form 4
22 Oct 2026Mark Bradley KayeSale560437.07244.76K USD27,562Form 4
22 Oct 2026Mark Bradley KayeSale240438.22105.17K USD27,322Form 4
22 Oct 2026Mark Bradley KayeSale1,160439.25509.53K USD26,162Form 4
22 Oct 2026Mark Bradley KayeSale1,720440.44757.56K USD24,442Form 4
22 Oct 2026Mark Bradley KayeSale2,343441.341.03M USD22,099Form 4
22 Oct 2026Mark Bradley KayeSale480442.61212.45K USD21,619Form 4
22 Oct 2026Mark Bradley KayeSale440443.81195.28K USD21,179Form 4
22 Oct 2026Mark Bradley KayeSale160444.8571.18K USD21,019Form 4
22 Oct 2026Mark Bradley KayeSale827446.05368.88K USD20,192Form 4
22 Oct 2026Mark Bradley KayeSale273447.19122.08K USD19,919Form 4
17 Jul 2026Ramiro G PeruPurchase1,000366.05366.05K USD10,908Form 4

Common questions about Elevance Health's executives and insiders

Source: Financial Modeling Prep